Arylsulfatase E (ARSE) Peptide
-
- Target See all Arylsulfatase E (ARSE) products
- Arylsulfatase E (ARSE)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KVVHHDPPLL FDLSRDPSET HILTPASEPV FYQVMERVQQ AVWEHQRTLS
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ARSE antibody,
Alternative Names: ARSE control peptide, ARSE antibody Blocking Peptide, Anti-ARSE Blocking Peptide, Arylsulfatase E Blocking Peptide, Chondrodysplasia Punctata 1 Blocking Peptide, CDPX Blocking Peptide, CDPX1 Blocking Peptide, CDPXR Blocking Peptide, MGC163310 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Arylsulfatase E (ARSE)
- Synonyms
- ASE Peptide, CDPX Peptide, CDPX1 Peptide, CDPXR Peptide, ARSE Peptide, MGC155058 Peptide, arylsulfatase E (chondrodysplasia punctata 1) Peptide, arylsulfatase E Peptide, ARSE Peptide, Arse Peptide
- Background
- Arylsulfatase E is a member of the sulfatase family. It is glycosylated postranslationally and localized to the golgi apparatus. Sulfatases are essential for the correct composition of bone and cartilage matrix. X-linked chondrodysplasia punctata, a disease characterized by abnormalities in cartilage and bone development, has been linked to mutations in this gene.
- Molecular Weight
- 62 kDa
-